Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
纳武利尤单抗治疗伴有 dMMR 或 MSI-H 的转移性罕见癌症的 II 期试验及其与免疫表型分析的关系(ROCK 试验)
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1807
Okuma, Hitomi S; Watanabe, Keisuke; Tsuchihashi, Kenji; Machida, Ryunosuke; Sadachi, Ryo; Hirakawa, Akihiro; Ariyama, Hiroshi; Kanai, Masashi; Kamikura, Masahisa; Anjo, Kenta; Hiramitsu, Akari; Sekine, Shigeki; Okita, Natsuko; Mano, Hiroyuki; Nishikawa, Hiroyoshi; Nakamura, Kenichi; Yonemori, Kan
肿瘤
肿瘤免疫
多发性骨髓瘤
多发性硬化症
ROCK
免疫/内分泌